Dabigatran Etexilate + Dronedarone Interaction
Moderateinteraction on record
Description
P-gp inhibitor requiring dosage reduction to 75 mg twice daily in patients with moderate renal impairment (CrCl 30-50 mL/min); avoid in severe renal impairment.
Mechanism
P-glycoprotein inhibition increases dabigatran exposure
Source: NLP:dabigatran etexilate